NKX2‐5/LHX1 and UHRF1 Establishing a Positive Feedback Regulatory Circuitry Drives Esophageal Squamous Cell Carcinoma through Epigenetic Dysregulation
Advanced Science · 2025
DOI: 10.1002/advs.202413508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xukun Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: The State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy …. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, LIM-Homeodomain Proteins, Transcription Factors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
DNA methylation regulators play critical roles in modulating oncogenic driver genes in cancers. However, the precise mechanisms through which these DNA methylation regulators influence oncogenesis and clinical therapy have yet to be fully elucidated. This study reveals that hypermethylation of under‐methylated regions (UMRs) within gene bodies is involved in the activation of oncogenic homeobox genes, particularly NKX2‐5 and LHX1, in esophageal squamous cell carcinoma (ESCC). Mechanistically, NKX2‐5 and LHX1 synergistically bind to the promoter region of UHRF1 , thereby augmenting its transcription. In turn, UHRF1 orchestrates the recruitment of DNMT1/DNMT3A, alongside NKX2‐5 and LHX1, to the UMRs of these genes, thereby increasing DNA methylation levels and their expression. This intricate interplay forms a positive transcriptional feedback loop between NKX2‐5/LHX1 and UHRF1, thus promoting the overexpression of all three genes and ultimately facilitating tumor growth. Notably, concurrent inhibition of UHRF1 and DNMTs impedes tumor growth by suppressing NKX2‐5 and LHX1 expression. Overall, this study identifies a positive feedback regulatory circuitry underlying the UMR hypermethylation‐mediated activation of oncogenic drivers in ESCC and proposes a promising therapeutic strategy for ESCC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021,…
- Shenzhen Key Laboratory of Epigenetics and Precision Medicine for Cancers, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academic of Medical Sciences an…
- Central Laboratory, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academic of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, P. R.…
- Oujiang Laboratory, Zhejiang Lab for Regenerative Medicine, Vision and Brain Health, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325101, P. R. China.
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P. R. China.
- Department of Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P. R. China.
ORCID-Profile: Xukun Li, Jianzhong Su, Zhihua Liu, Hongyan Chen
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- CAMS Innovation Fund for Medical Sciences
- Fundamental Research Funds for the Central Universities
- Shenzhen Science and Technology Program
- National Key Research and Development Program of China
- Shenzhen Science and Technology Innovation Program
Zitieren
APA
Li, X., Fan, D., Li, Y., Yuan, J., Sun, W., Zhu, Q., Qi, L., Wu, X., Cai, J., Gong, T., Zhao, N., Su, J., Liu, Z., & Chen, H. (2025). NKX2‐5/LHX1 and UHRF1 Establishing a Positive Feedback Regulatory Circuitry Drives Esophageal Squamous Cell Carcinoma through Epigenetic Dysregulation. Advanced Science. https://doi.org/10.1002/advs.202413508
Vancouver
Li X, Fan D, Li Y, Yuan J, Sun W, Zhu Q, et al. NKX2‐5/LHX1 and UHRF1 Establishing a Positive Feedback Regulatory Circuitry Drives Esophageal Squamous Cell Carcinoma through Epigenetic Dysregulation. Advanced Science. 2025. doi:10.1002/advs.202413508
BibTeX
@article{Li2025,
author = {Li, Xukun and Fan, Dandan and Li, Yong and Yuan, Jian and Sun, Wanyuan and Zhu, Qinghao and Qi, Ling and Wu, Xueling and Cai, Jiahui and Gong, Tongyang and Zhao, Ning and Su, Jianzhong and Liu, Zhihua and Chen, Hongyan},
title = {NKX2‐5/LHX1 and UHRF1 Establishing a Positive Feedback Regulatory Circuitry Drives Esophageal Squamous Cell Carcinoma through Epigenetic Dysregulation},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202413508}
}
EUVIMED